IMPROVED VACCINE

EXOGENOUS GENE EXPRESSION IN RECOMBINANT ADENOVIRUS FOR MINIMAL IMPACT ON VIRAL KINETICS

COMPOSITIONS AND METHODS FOR GENERATING A PERSISTING POPULATION OF T CELLS USEFUL FOR THE TREATMENT OF CANCER

CORONAVIRUS VACCINE

TARGETED INTEGRATION OF NUCLEIC ACIDS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

RNA CONSTRUCTS AND USES THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

Coronavirus vaccine

CODON OPTIMIZED GLA GENES AND USES THEREOF

Codon optimized GLA genes and uses thereof

Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics

IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS

Coronavirus vaccine

Heterologous UTR sequences for enhanced mRNA expression

RNA constructs and uses thereof

RNA constructs and uses thereof

Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer

Codon optimized GLA genes and uses thereof

Targeted integration of nucleic acids

Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

Modified polynucleotides for the production of secreted proteins

Modified polynucleotides for the production of secreted proteins

Triple vector for expressing antibody molecules in full therapeutic format

Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer

Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics

Heterologous UTR sequences for enhanced mRNA expression

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

Modified polynucleotides for the production of oncology-related proteins and peptides

COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING CELL DEATH BY A TRANSLATION REGULATED GENE EXPRESSION SYSTEM

Modified polynucleotides for the production of secreted proteins

Method for improving efficiency of inducing pluripotent stem cell

Modified polynucleotides for the production of proteins associated with human disease

Modified polynucleotides for the production of nuclear proteins

Modified polynucleotides for the production of secreted proteins

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Mitochondrial targeted RNA expression system and use thereof

Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system

Methods for treating spinal muscular atrophy

Viral Vectors and Methods of Use

Long-term in vivo transgene expression

Treatment of diabetes with synthetic beta cells

Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells